Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hollings Renton


  • Director at Anaptysbio Inc (ANAB), 2020-02-13
  • Director at Portola Pharmaceuticals Inc (PTLA), 2019-11-05
  • Director at Zymeworks Inc. (ZYME), 2019-05-08
  • Director at Cepheid (CPHD), 2016-11-08
  • Director at Kythera Biopharmaceuticals Inc (KYTH), 2015-10-02
  • Director at Rigel Pharmaceuticals Inc (RIGL), 2013-05-28
  • Director at Affymax Inc (AFFY), 2012-06-18
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PTLA $30.00 5,000 Director 13,194 2019-11-01 Filing
PTLA $30.00 5,000 Director 13,194 2019-08-08 Filing
PTLA $35.07 400 Director 9,000 2019-04-15 Filing
PTLA $34.40 4,600 Director 9,400 2019-04-15 Filing
PTLA $38.33 10,520 Director 0 2015-05-11 Filing